AMACR and posterior cortical atrophy: Emerging evidence suggests that serum biomarkers, including α-methylacyl-CoA racemase (AMACR) and zinc finger protein-like 1 (ZFPL1), may provide additional prognostic information beyond conventional clinicopathological factors.<h4>Materials and methods</h4>This single-center retrospective study included 115 patients with PCa who underwent radical prostatectomy.